Search Results - "Kapler, Jeff"

Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients by O'Neil, Conar R, Pang, Jack Xq, Lee, Samuel S, Swain, Mark G, Burak, Kelly W, Klein, Patricia, Myers, Robert P, Kapler, Jeff, Gill, Michael J, Labrie, Martin, Coffin, Carla S

Get full text

Role of the pharmacist caring for people at risk of or living with HIV in Canada by Tkachuk, Stacey, Ready, Erin, Chan, Shanna, Hawkes, Jennifer, Janzen Cheney, Tracy, Kapler, Jeff, Kreutzwiser, Denise, Akagi, Linda, Coombs, Michael, Giguere, Pierre, Hughes, Christine, Kelly, Deborah, Livingston, Sheri, Martel, Dominic, Naccarato, Mark, Nhean, Salin, Pozniak, Carley, Ramsey, Tasha, Robinson, Linda, Smith, Jonathan, Swidrovich, Jaris, Symes, Jodi, Yoong, Deborah, Tseng, Alice

Get full text

Venous thromboembolism due to suspected interaction between rivaroxaban and nevirapine by Bates, Duane, Dalton, Bruce, Gilmour, Janet, Kapler, Jeff

Get full text

Venous Thromboembolism Due to Suspected Interaction Between Nevirapine and Rivaroxaban by Bates, Duane, Dalton, Bruce, Gilmour, Janet, Kapler, Jeff

Get full text

Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines by Tseng, Alice, Foisy, Michelle, Hughes, Christine A, Kelly, Deborah, Chan, Shanna, Dayneka, Natalie, Giguère, Pierre, Higgins, Niamh, Hills-Nieminen, Cara, Kapler, Jeff, la Porte, Charles J L, Nickel, Pam, Park-Wyllie, Laura, Quaia, Carlo, Robinson, Linda, Sheehan, Nancy, Stone, Shannon, Sulz, Linda, Yoong, Deborah

Get full text

Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients by Aspinall, Alex I, Shaheen, Abdel A, Kochaksaraei, Golasa S, Haslam, Breean, Lee, Samuel S, Macphail, Gisela, Kapler, Jeff, Larios, Oscar E, Burak, Kelly W, Swain, Mark G, Borman, Meredith A, Coffin, Carla S

“…High hepatitis C cure rates have been observed in registration trials with second-generation direct-acting antivirals. Real-world data also indicate high…”
Get full text

LETTER TO THE EDITOR by O'Neil, Conar R, Pang, Jack X Q, Lee, Samuel S, Swain, Mark G, Burak, Kelly W, Klein, Patricia, Myers, Robert P, Kapler, Jeff, Gill, Michael J, Labrie, Martin, Coffin, Carla S

Get full text